Creation of the French-Brazilian Society

The French-Brazilian Oncology Society was created after the first French-Brazilian Oncology Congress, which took place in Paris, France, from the 19th to the 23rd of June 2000, at the Gustave Roussy Institute.

The congress was held thanks to the joint effort of the Director of the Gustave Roussy Institute, Professor Thomas Tursz, and the official representative of the Brazilian Oncology Society Dr. Carla Ismael.

Over 200 Brazilian and French physicians attended the first Congress, which had scientific sessions during a five-day meeting.

The purpose of this first French-Brazilian Congress was to establish greater collaboration and exchange of knowledge between the Brazilian Medical Oncology Community, which was represented by all specialties (cancer surgery, clinical oncology practice, radiotherapy, nuclear medicine), and the European Scientific Community, especially the French one.

The first French-Brazilian Congress was a success both as a scientific and social event. Many different social gatherings took place during the meeting, which enabled professionals to exchange ideas, make new contacts and socialize in a warm and friendly atmosphere.

The same spirit guided the second French-Brazilian Oncology Congress at the Sofitel Hotel, in Rio de Janeiro, Brazil, which took place from October 29th to November 1st of 2002.

This French-Brazilian Oncology Congress counted on the support of the Brazilian Clinical Oncology Society (Sociedade Brasileira de Oncologia Clínica – SBOC), the Brazilian Cancer Society (Sociedade    Brasileira    de

Cancerologia– SBC), the Brazilian Breast Society (Sociedade Brasileira de Mastologia – SBM), the Brazilian Radiotherapy Society (Sociedade Brasileira de Radioterapia – SBR) and the National Cancer Institute (Instituto Nacional do Câncer – INCA).

The French party counted on the support of the Gustave Roussy Institute, which was represented by its Director and Congress Chairman Professor Thomas Tursz, as well as on the support of the Societé Française du Cancer.

The main theme of the Congress was “New Tendencies in Cancer Treatment”. This theme enabled the Brazilian and French participants to discuss the treatments available for the most common tumors; e.g. breast cancer, colon-rectal cancer, lung cancer, prostate cancer and hematological tumors.

Over 600 physicians as well as 20 international and celebrated guests participated in this event.